Report DMCA FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.